Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);费用效益分析(Cost-Benefit Analysis);无病生存(Disease-Free Survival);人类(Humans);模型, 经济学(Models, Economic);随机对照试验(主题)(Randomized Controlled Trials as Topic);技术评估, 生物医学(Technology Assessment, Biomedical);泌尿系肿瘤(Urologic Neoplasms)
DOI
10.1007/s40273-018-0689-3
PMID
30030817
发布时间
2020-03-06
- 浏览19

PharmacoEconomics
19-27页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文